Pain and emotion
Chapter 10 endnote 19, from Lisa Feldman Barrett.
Some context is:
It’s even possible that nociception is a form of interoception.
Interoceptive and nociceptive signals from your body meet in the brainstem and travel to the rest of your brain along the same ascending pathways (C, Aδ, Lamina I and vagus pathways). As your body speaks to your brain, interoceptive sensations from various causes (exercise, stress, etc.) are indistinguishable, and nociception is strongly related. Furthermore, there is crosstalk among the neurons, meaning that the signals influence one another along these paths.The neurons are unmyelinated, or lightly myelinated, meaning that the signal will move slowly along each axon, but signals from different neurons can influence one another as their signals move along the axons themselves and not just at the synapses. Instances of pain and emotion can be distinguished, but nociceptive and interoceptive sensations might contribute to both.
So what does it mean when a scientist reports that emotion can enhance or diminish pain? The answer: “emotion induction” is changing inner body predictions, which changes the dial on nociception and pain. When the brain constructs an emotion concept, this contains contain interoceptive predictions that can change affect, and negative affect changes physical discomfort into suffering.
Predictions can cause opioid release, which turns down nociception in the brainstem, but also there are opioid receptors in other parts of the interoceptive network and even in spinal cord. So opioids dial down not only nociception but also inner body changes that have implications for interoception and affect. Opioids, for example, which are released during placebo, not only reduce experienced pain, but also reduce autonomic nervous system reactivity, as well as brainstem and spinal cord responses to painful stimulation. Placebo effects even influence the release of another neurotransmitter, dopamine, which used to be considered a “reward” neurotransmitter, but actually is better understood as the juice for effortful action (that's usually needed to obtain a reward). It juices the system to allow a person to seek the reward, but the rewarding properties themselves appear to derive from opioids (and possibly another system, called the cannabinoid system — internal marijuana).
Notes on the Notes
- Craig, A. D. 2015. How Do You Feel? An Interoceptive Moment with Your Neurobiological Self. Princeton, NJ: Princeton University Press.
- Damasio, Antonio, and Gil B. Carvalho. 2013. “The Nature of Feelings: Evolutionary and Neurobiological Origins.” Nature Reviews Neuroscience 14 (2): 143–152.
- Robinson, Lucy F., Lauren Y. Atlas, and Tor D. Wager. 2015. "Dynamic functional connectivity using state-based dynamic community structure: Method and application to opioid analgesia." NeuroImage 108: 274-291.
- Kucyi, Aaron, and Karen D. Davis. 2015. "The dynamic pain connectome." Trends in Neurosciences 38 (2): 86-95.
- Tracey, Irene, and Patrick W. Mantyh. 2007. "The cerebral signature for pain perception and its modulation." Neuron 55 (3): 377-391.
- Legrain, Valery, Gian Domenico Iannetti, Léon Plaghki, and André Mouraux. 2011. "The pain matrix reloaded: a salience detection system for the body." Progress in Neurobiology 93 (1): 111-124.
- Price, Donald D., Damien G. Finniss, and Fabrizio Benedetti. 2008. "A comprehensive review of the placebo effect: recent advances and current thought." Annual Review of Psychology 59: 565-590.
- Bushnell, M. Catherine, Marta Čeko, and Lucie A. Low. 2013. "Cognitive and emotional control of pain and its disruption in chronic pain." Nature Reviews Neuroscience 14 (7): 502-511
- Fields, Howard. "State-dependent opioid control of pain." 2004. Nature Reviews Neuroscience 5 (7): 565-575.
- Wager & Atlas, 2015
- Fields, Howard L., and Elyssa B. Margolis. 2015. "Understanding opioid reward." Trends in Neurosciences 38 (4): 217-225.